Literature DB >> 23519584

Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application.

Christoph Sinning1, Lars Lillpopp, Sebastian Appelbaum, Francisco Ojeda, Tanja Zeller, Renate Schnabel, Edith Lubos, Annika Jagodzinski, Till Keller, Thomas Munzel, Christoph Bickel, Stefan Blankenberg.   

Abstract

BACKGROUND: Severity of coronary artery disease (CAD) is related to cardiovascular outcome. We aimed to assess the long-term follow-up depending on Synergy between percutaneous coronary intervention with Taxus and cardiac surgery (SYNTAX) and Gensini score for prognosis. Both scores increase with complexity and thus reflect risk of cardiovascular events. METHODS AND
RESULTS: We determined complexity and extent of CAD by the SYNTAX and Gensini score in the AtheroGene cohort (N = 1,974, with 22.6 % women). The endpoint was non-fatal myocardial infarction (N = 132) and cardiovascular death (N = 159) over a median follow-up of 5.4 (Q1: 5.23/Q3: 5.57) years up to 8 years maximum (follow-up rate 99.4%). For SYNTAX score, the following distribution was used: low (≤22, N = 1,404), medium (23-32, N = 314), high score (>32, N = 256). Gensini score was split into thirds. Cox regression analysis showed a hazard ratio (HR) of 1.5 (95% confidence interval 1.16-1.95; p = 0.0024) for the log transformed SYNTAX score in a fully adjusted model and a HR of 1.41 (95% CI 1.13-1.77; p = 0.0025) for the Gensini score. The SYNTAX score alone had a C-index of 0.62, whereas adding clinical variables increased the C-index to 0.67. Similar results were obtained for the Gensini score. Regarding the SYNTAX score using net reclassification index, discrimination of events and non-events was enhanced by 37.2% in a model of clinical variables and biomarkers and by 31.8% for the Gensini score.
CONCLUSION: The SYNTAX and Gensini score in combination with clinical variables could be used to predict the cardiovascular prognosis during a long-term follow-up of up to 8 years in CAD patients.

Entities:  

Mesh:

Year:  2013        PMID: 23519584     DOI: 10.1007/s00392-013-0555-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  23 in total

1.  [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations].

Authors:  C W Hamm
Journal:  Z Kardiol       Date:  2004-01

2.  SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.

Authors:  Chrysafios Girasis; Scot Garg; Lorenz Räber; Giovanna Sarno; Marie-Angèle Morel; Hector M Garcia-Garcia; Thomas F Lüscher; Patrick W Serruys; Stephan Windecker
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

3.  Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.

Authors:  Davide Capodanno; Anna Caggegi; Marco Miano; Glauco Cincotta; Fabio Dipasqua; Giuseppe Giacchi; Piera Capranzano; Gianpaolo Ussia; Maria Elena Di Salvo; Alessio La Manna; Corrado Tamburino
Journal:  JACC Cardiovasc Interv       Date:  2011-03       Impact factor: 11.195

4.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

5.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

6.  A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.

Authors:  Scot Garg; Giovanna Sarno; Chrysafios Girasis; Pascal Vranckx; Ton de Vries; Michael Swart; Marco Bressers; Hector M Garcia-Garcia; Gerrit-Anne van Es; Lorenz Räber; Gianluca Campo; Marco Valgimigli; Keith D Dawkins; Stephan Windecker; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2011-06       Impact factor: 11.195

7.  Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease.

Authors:  Christoph R Sinning; Jan-Malte Sinning; Andreas Schulz; Renate B Schnabel; Edith Lubos; Philipp S Wild; Jana Papassotiriou; Andreas Bergmann; Stefan Blankenberg; Thomas Munzel; Christoph Bickel
Journal:  Circ J       Date:  2011-03-03       Impact factor: 2.993

8.  Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world.

Authors:  Hiroki Shiomi; Toshihiro Tamura; Shunichiro Niki; Tomohisa Tada; Junichi Tazaki; Masanao Toma; Koh Ono; Tetsuo Shioi; Takeshi Morimoto; Masaharu Akao; Yutaka Furukawa; Yoshihisa Nakagawa; Takeshi Kimura
Journal:  Circ J       Date:  2011-03-30       Impact factor: 2.993

9.  Assessment of the SYNTAX score in the Syntax study.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Giovanna Sarno; Marcel van den Brand; Arie-Pieter Kappetein; Nic Van Dyck; Michael Mack; David Holmes; Ted Feldman; Marie-Claude Morice; Antonio Colombo; Eric Bass; Katrin Leadley; Keith D Dawkins; Gerrit-Anne van Es; Marie-Angèle M Morel; Friedrich W Mohr
Journal:  EuroIntervention       Date:  2009-05       Impact factor: 6.534

10.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

View more
  56 in total

1.  Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.

Authors:  Tassilo Bonzel; Volker Schächinger; Hilmar Dörge
Journal:  Clin Res Cardiol       Date:  2015-10-27       Impact factor: 5.460

2.  Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome.

Authors:  Sai Lv; Wei Liu; Yujie Zhou; Yuyang Liu; Dongmei Shi; Yingxin Zhao; Xiaoli Liu; Jumana W Alhelal; K S Shakeenah Ravuru
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

3.  Association of epicardial fat thickness with TIMI risk score.

Authors:  S Balta; U Canpolat
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

4.  Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis.

Authors:  George Andrikopoulos; Stylianos Tzeis; Dimitrios Terentes-Printzios; Christos Varounis; Charalampos Vlachopoulos; Ioannis Mantas; Sotirios Patsilinakos; Stylianos Lampropoulos; Christoforos Olympios; Athanasios Kartalis; Athanasios Manolis; Alexandros Gotsis; Filippos Triposkiadis; Themistoklis Tsaknakis; Ioannis Goudevenos; Ioannis Kaprinis; Athanasios Pras; Fotios Vasiliou; Emmanouil Skoumpourdis; Gerasimoula Sakka; Antonios Draganigos; Panos Vardas
Journal:  Clin Res Cardiol       Date:  2015-12-10       Impact factor: 5.460

5.  SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease.

Authors:  Christoph Sinning; Elvin Zengin; Christoph Waldeyer; Moritz Seiffert; Renate B Schnabel; Edith Lubos; Tanja Zeller; Christoph Bickel; Stefan Blankenberg; Peter M Clemmensen; Dirk Westermann
Journal:  Clin Res Cardiol       Date:  2016-06-30       Impact factor: 5.460

6.  Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.

Authors:  B Titz; S Dietrich; T Sadowski; C Beck; A Petersen; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

7.  Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemia.

Authors:  Di Sun; Bing-Yang Zhou; Xi Zhao; Sha Li; Cheng-Gang Zhu; Yuan-Lin Guo; Ying Gao; Na-Qiong Wu; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Clin Lab Anal       Date:  2018-03-30       Impact factor: 2.352

8.  Prognostic utility of serum vitronectin levels in acute myocardial infarction.

Authors:  S Aslan; B Ikitimur; H A Cakmak; B Karadag; E Y Tufekcioglu; H Ekmekci; H Yuksel
Journal:  Herz       Date:  2014-05-15       Impact factor: 1.443

9.  Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study.

Authors:  Imo E Hoefer; Jan-Willem Sels; J Wouter Jukema; Sandrin Bergheanu; Erik Biessen; Elizabeth McClellan; Mat Daemen; Pieter Doevendans; Philip de Groot; Marieke Hillaert; Sebastiaan Horsman; Mustafa Ilhan; Johan Kuiper; Nico Pijls; Ken Redekop; Peter van der Spek; Andrew Stubbs; Eric van de Veer; Johannes Waltenberger; Anton-Jan van Zonneveld; Gerard Pasterkamp
Journal:  Clin Res Cardiol       Date:  2013-08-23       Impact factor: 5.460

10.  Correlation between the serum procalcitonin level and the extension and severity of coronary artery disease in patients with non-ST-segment elevation myocardial infarction.

Authors:  Seyed-Vahid Hashemipour; Hamidreza Pourhosseini; Ali Hosseinsabet
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.